Skip to content

Author

Alessandro Gringeri

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

CO-01 | BLEEDING EVENTS IN MILD HEMOPHILIA A AND VON WILLEBRAND DISEASE TYPE 1 YEARLY TREATABLE WITH DESMOPRESSIN IN ITALY

Background. Subcutaneous and intranasal desmopressin is safe and effective in type 1 VWD and particularly convenient for pediatric use and home treatment. Thus, it can reduce in-hospital admissions and inherent costs and favor adherence and the prompt control of bleeding. Nevertheless, it is often underused or unavaila...

Alessandro Gringeri · 0 citations
Open access Oct 2026

CO-07 | ITALIAN RESOURCE USE IN MILD HEMOPHILIA A AND TYPE 1 VON WILLEBRAND DISEASE

Introduction. Hemophilia A and von Willebrand disease (VWD) are the most common inherited bleeding disorders, resulting from low or dysfunctional factor VIII (FVIII) and von Willebrand factor (VWF), respectively. The purpose of the following analysis is to quantify the potential savings through desmopressin (DDAVP) use...

Alessandro Gringeri · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.